[Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer's disease: the role of the ApoE genotype].
E V PonomarevaSvetlana I GavrilovaI V KolykhalovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
The results can form the basis for the development of therapeutic measures aimed at preventing the progression of cognitive impairment and the development of dementia in the first degree relatives of patients with AD as those with the highest risk of dementia.